Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- Unveiling the Biomechanical Forces that Drive Scarring.
- Scientists Discover Class of Crystals With Properties That May Prove Revolutionary.
- Will Banning Food Dyes Improve Our Health?
- Backed by Science and Evidence, New Jersey’s Actions Aim to Advance Maternal Health.
- When Doctors Dismiss Symptoms, Patients Suffer Lasting Harm.
Categories
- Community (2,289)
- Covid (987)
- CTO Events (6)
- News (2,914)
- Pilots (21)